Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Clin Periodontol ; 39(7): 608-16, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22582749

RESUMO

AIM: This study aimed to investigate whether chronic antigen-induced arthritis (AIA) influences infection-induced periodontitis (PD) in mice and whether PD modifies the clinical course of AIA. The contribution of anti-TNF-α therapy was also evaluated. MATERIALS AND METHODS: The PD was induced in C57BL/6 mice by oral infection with Aggregatibacter actinomycetemcomitans. AIA was induced after infection. Anti-TNF-α and chlorhexidine therapies were used to investigate the role of TNF-α and oral infection on PD and AIA interaction. Maxillae, knee joints, lymph nodes and serum samples were used for histomorphometric, immunoenzymatic and/or real time-PCR analyses. RESULTS: Antigen-induced arthritis exacerbated alveolar bone loss triggered by PD infection. In contrast, PD did not influence AIA in the evaluated time-points. PD exacerbation was associated with enhanced production of IFN-γ in maxillae and expression of the Th1 transcription factor tBET in submandibular lymph nodes. Increased serum levels of IL-6 and C-reactive protein were also detected. Anti-TNF-α and antiseptic therapies prevented the development and exacerbation of infectious-PD. Anti-TNF-α therapy also resulted in reduced expression of IFN-γ, TNF-α and IL-17 in maxillae. CONCLUSIONS: Altogether, the current results indicate that the exacerbation of infection-induced PD by arthritis is associated with an alteration in lymphocyte polarization pattern and increased systemic immunoreactivity. This process was ameliorated by anti-TNF-α and antiseptic therapies.


Assuntos
Infecções por Actinobacillus/microbiologia , Aggregatibacter actinomycetemcomitans/fisiologia , Artrite Experimental/imunologia , Periodontite/microbiologia , Fosfatase Ácida/análise , Infecções por Actinobacillus/tratamento farmacológico , Perda do Osso Alveolar/imunologia , Perda do Osso Alveolar/microbiologia , Animais , Anti-Infecciosos Locais/uso terapêutico , Artrite Experimental/tratamento farmacológico , Artrite Experimental/microbiologia , Proteína C-Reativa/análise , Clorexidina/uso terapêutico , Colágeno Tipo I/imunologia , Imunoglobulina G/sangue , Interferon gama/análise , Interleucina-17/análise , Interleucina-6/sangue , Isoenzimas/análise , Linfonodos/patologia , Masculino , Maxila/patologia , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos , Osteoclastos/patologia , Periodontite/tratamento farmacológico , Periodontite/imunologia , Proteínas com Domínio T/análise , Fosfatase Ácida Resistente a Tartarato , Fator de Necrose Tumoral alfa/antagonistas & inibidores
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA